Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market Report

Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market Analysis By Product (Nanoparticles and Embolization Particles), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2018 - 2025

  • Published Date: Dec, 2017
  • Base Year for Estimate: 2016
  • Report ID: GVR-2-68038-267-9
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2015
  • Number of Pages: 92

Industry Insights

The global novel drug delivery systems (NDDS) in cancer therapy market size was valued at USD 4.31 billion in 2016 and is projected to grow at a CAGR of 22.9% during the forecast period. Worldwide increasing incidence of cancer, availability of research funding, increase in awareness about alternative methods for treatment, and favorable reimbursement scenarios in developed nations are some of the key drivers of this market. In addition, use of nanoparticles to treat cancers is expected to boost market growth.

U.S. NDDS in cancer therapy market

Key players in the market are investing in R&D for novel drug delivery systems. For instance, Celgene Corporation’s R&D expenditures increased from USD 3,697.3 million in 2015 to USD 4,470.1 million in 2016. This increase was directed toward expanding product portfolio and obtaining regulatory approvals for new products. 

However, lack of awareness about alternative therapies and inadequate funds for development of novel drug delivery systems are expected to impede the growth of the novel drug delivery systems in cancer therapy market during the forecast period. Cancer research projects require huge investment and funding. Although developed nations like U.S., U.K., and Germany have many organizations that fund new technologies, research projects in countries like Brazil, Mexico, and India are not funded adequately. In addition, awareness about new and alternative treatments is very low in these countries.

Product Insights

Based on type of novel drug delivery systems, the market is segmented into nanoparticles and embolization particles. Nanoparticles are further segmented into liposomes, polymers, micelles, and other nanoparticles. In 2016, the nanoparticles segment held the largest market share by product and is expected to continue its dominance over the novel drug delivery systems in cancer therapy market throughout the forecast period.

Nanoparticles as novel drug delivery systems are a unique approach in cancer treatment. They encapsulate the drugs and protect them against chemical and enzymatic degradation. Nanoparticles in drug delivery provide long circulation half-lives, help in reducing side effects, and improve pharmacokinetics. These particles also offer enhanced permeability, which allows efficient delivery of drugs to cancer tissues. Nanoparticles as novel drug delivery systems are thus considered a promising approach to replace traditional chemotherapy, a treatment that poses a serious risk to healthy tissues.

Nanoparticle delivery systems such as liposomes and micelles are often used to increase drug efficacy and DNA delivery and targeting. Continuous improvements in therapeutic properties of drugs have increased the demand for novel drug delivery systems. In 2016, liposomes held the largest share in the nanoparticles segment, by type. This sub-segment is also expected to grow at the highest rate during the forecast period.

Tumor embolization is a process of blocking blood vessels that supply oxygen and blood to tumors. The embolization particles segment is further categorized into PVA particles, drug eluting beads, liquid emboli, and other embolization particles. These particles are injected into small vessels supplying blood to cancer cells. This procedure allows for easy surgical resection of cancer cells, resulting from reduced blood loss.

Regional Insights

North America dominated the novel drug delivery systems in cancer therapy market in 2016 with a revenue share of around 36.8%. Key factors contributing to the growth of this market include rise in number of research activities for new therapies, increase in budget for novel drug discovery, growing awareness due to marketing and promotional activities of manufcaturers, and increase in incidence of cancer. In addition, FDA approvals for commercial availabilty of NDDS and rise in number of clinical trilas for this therapy are expected to boost market growth in this region.

NDDS in cancer therapy market

The Asia Pacific market for novel drug delivery systems in cancer therapy is anticipated to grow at the fastest rate during the forecast period. This can be attributed to rise in incidence of cancer in China and Japan, increase in geriatric population in Japan, collaborations between U.S. and China to strengthen cancer research, and rise in awareness about new therapies in Asia Pacific. In addition, increase in research activities in Asia Pacific countries is expected to boost market growth during the forecast period.

Europe held the second-largest share in the novel drug delivery systems in cancer therapy market in 2016. The European market is expected to grow significantly owing to presence of a large number of cancer patients, rise in research funding for cancer therapies, increase in awareness about novel therapies among cancer patients, and high healthcare expenditure in the region.

Competitive Insights

Some of the key players operating in the market for novel drug delivery systems in cancer therapy are Teva Pharmaceutical Industries Ltd.; Johnson & Johnson Services, Inc.; GALEN; Merrimack Pharmaceuticals, Inc.; Shire; Samyang Biopharmaceuticals Corporation; Celgene Corporation; Spectrum Pharmaceuticals, Inc.; and BTG. Frequent product launches, geographic expansions, and distribution agreements to increase customer base are some of the key strategies players are undertaking to increase their share.

Report Scope

Attribute

Details

Base year for estimation

2016

Actual estimates/Historic data

2014 - 2015

Forecast period

2017 - 2025

Market representation

Revenue in USD Million & CAGR from 2017 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America, MEA

Country scope

U.S., Canada, Germany, U.K., Japan, China, Brazil, Mexico, South Africa

Report coverage

Revenue forecast, competitive landscape, growth factors, and trends

15% free customization scope (equivalent to 5-analyst working days)

If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization


Segments Covered in the Report

This report forecasts revenue growth and provides analysis on industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research, Inc. has segmented the novel drug delivery systems (NDDS) in cancer therapy market on the basis of product and region:

  • Product Outlook (Revenue, USD Million, 2014 - 2025)

    • Nanoparticles

      • Liposomes

      • Polymers

      • Micelles

      • Other nanoparticles

    • Embolization particles

      • PVA particles

      • Drug eluting beads

      • Liquid emboli

      • Other embolization particles

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

    • Asia Pacific

      • Japan

      • China

    • Latin America

      • Brazil

      • Mexico

    • MEA

      • South Africa

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $5,950
Multi User (2-5) - $7,950
Enterprise Access - $9,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified